Showing 4061-4070 of 7373 results for "".
- Restoration Robotics has Harvested the 10 Millionth Hair with the Artas® Robotic Systemhttps://practicaldermatology.com/news/20141024-restoration_robotics_has_harvested_the_10_millionth_hair_with_the_artas_robotic_system/2459080/Dr. Eduardo López Bran, a member of the International Society of Hair Restoration Society said, "We are excited to have harvested the 10 millionth hair. “It is important that my practice continues to offer the most advanced hair restoration procedures to our patients. The ARTAS Robotic Sys
- FDA Advisory Committee Recommends Approval of Secukinumab for Moderate to Severe Plaque Psoriasishttps://practicaldermatology.com/news/20141020-fda_advisory_committee_recommends_approval_of_secukinumab_for_moderate_to_severe_plaque_psoriasis/2459081/The Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) to the FDA voted 7 to 0 to support the approval of AIN457 (secukinumab), a selective interleukin-17A (IL-17A) inhibitor, for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates
- Novel Molecule Promising in Hyperhidrosis Pilot Studyhttps://practicaldermatology.com/news/20141016-novel_molecule_promising_in_hyperhidrosis_pilot_study/2459082/The outcome of a pilot study of BBI-4000, new compound for the topical treatment of primary axillary hyperhidrosis, support the potential for BBI-4000 to become a safe and effective treatment option for people suffering from excessive sweating. BBI-4000 is a new molecular entity from Brickell Biotec
- New Data for Topical Nitric Oxide Nanoparticles: Evidence in Animal Model of EDhttps://practicaldermatology.com/news/20141014-new_data_for_topical_nitrous_oxide_nanoparticles_evidence_in_animal_model_of_ed/2459086/Topically applied nitric oxide-releasing nanoparticles (NO-NPs) induced spontaneous erections and increased basal ICP in an animal model of radical prostatectomy. According to findings published in The Journal o
- Researchers to Present Gigapixel Whole-Body Camera at OSA Annual Meetinghttps://practicaldermatology.com/news/20141008-researchers_to_present_gigapixel_whole-body_camera_at_osa_annual_meeting/2459091/A new “gigapixel whole-body photographic camera” may provide an option for tracking changes in potentially cancer skin lesions. Duke University researchers who developed the imaging technology will presenting it at the The Optical Society's (OSA) 98th Annual Meeting, Frontiers in Optics, Oct. 19-23
- Sirona Biochem: Obagi Medical Products Begins Manufacturing Scale-Up of Skin Lightening Agenthttps://practicaldermatology.com/news/20141008-sirona_biochem_obagi_medical_products_begins_manufacturing_scale-up_of_skin_lightening_agent/2459092/Sirona Biochem Corp. announced that its partner Obagi Medical Products Inc., a wholly-owned subsidiary of Valeant Pharmaceuticals International Inc., has started manufacturing scale-up of the skin lightening compound (TFC-849) originally developed by Sirona's scientists in Franc
- Peter Barton Hutt Appointed to Suneva Medical, Inc. Board Of Directorshttps://practicaldermatology.com/news/20141008-peter_barton_hutt_appointed_to_suneva_medical_inc_board_of_directors/2459093/Peter Barton Hutt was appointed a member of the Board of Directors of Suneva Medical, Inc., a privately-held aesthetics company. Mr. Hutt has specialized in food and drug law at the Washington, DC firm of Covington and Burling since 1960, pausing only to serve as Chief Counsel o
- Galderma Initiates US Study of Novel Muscle Relaxant for Aesthetic Dermatology and Cosmetic Surgeryhttps://practicaldermatology.com/news/20141006-galderma_initiates_us_study_of_novel_muscle_relaxant_for_aesthetic_dermatology_and_cosmetic_surgery/2459095/Galderma has initiated a Phase II clinical trial of a novel muscle relaxant in the US. The Phase II clinical trial is a multicenter, dose-ranging study designed to evaluate the safety and effectiveness of Galderma's internally developed liquid form of botulinum toxin for the tre
- Mission Pharmacal Unveils New Lotion for Seborrheic Dermatitishttps://practicaldermatology.com/news/20140930-mission_pharmacal_unveils_new_lotion_for_seborrheic_dermatitis/2459100/To help bring a treatment option to people afflicted with common skin disorders including seborrheic dermatitis (SD), Mission Pharmacal Company has unveiled Ovace Plus Lotion (sodium sulfacetamide 9.8%). Ovace Plus Lotion joins Ovace Plus Wash (sodium sulfacetamide 10%) Cleansing Gel and Ovace Plus
- Cynosure Receives Expanded FDA Clearance to Market PicoSure for Treatment of Wrinkleshttps://practicaldermatology.com/news/20140924-cynosure_receives_expanded_fda_clearance_to_market_picosure_for_treatment_of_wrinkles/2459105/Cynosure, Inc. has received FDA 510(k) clearance to market its PicoSure Picosecond Laser Workstation for the treatment of wrinkles with the company's new disposable energy delivery system, the FOCUS lens array. In the fourth quarter of 2012, PicoSure recieve